Overview
Hiroshi Kanno practices in Japan. Mr. Kanno is rated as an Experienced expert by MediFind in the treatment of Ependymoma. His top areas of expertise are Von Hippel-Lindau (VHL) Syndrome, Hemangioblastoma, Hemangioma, and Renal Cell Carcinoma (RCC).
His clinical research consists of co-authoring 42 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Ependymoma.
Locations
Kawasaki, Japan
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HemangioblastomaMr. Kanno isDistinguished. Learn about Hemangioblastoma.
- Von Hippel-Lindau (VHL) SyndromeMr. Kanno isDistinguished. Learn about Von Hippel-Lindau (VHL) Syndrome.
- Advanced
- HemangiomaMr. Kanno isAdvanced. Learn about Hemangioma.
- Experienced
- Blood ClotsMr. Kanno isExperienced. Learn about Blood Clots.
- Brain TumorMr. Kanno isExperienced. Learn about Brain Tumor.
- Disseminated Intravascular Coagulation
- EpendymomaMr. Kanno isExperienced. Learn about Ependymoma.
- GliomaMr. Kanno isExperienced. Learn about Glioma.
- Gliomatosis CerebriMr. Kanno isExperienced. Learn about Gliomatosis Cerebri.